Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Robert J Terifay. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Robert J Terifay har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Commercial 32.300
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Robert J Terifay. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Robert J Terifay som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 32.300 32.300
2017-08-11 2017-08-10 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.921 0 -100,00
2017-08-11 2017-08-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.921 25.214 8,25 52,03 99.950 1.311.884
2017-06-19 2017-06-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -21.147 23.293 -47,59 468,19 -9.900.814 10.905.550
2017-06-19 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -48.750 30.579 -61,45
2017-06-19 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -22.192 44.440 -33,31 468,69 -10.401.168 20.828.584
2017-06-19 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.411 66.632 -7,51 468,69 -2.536.082 31.229.752
2017-06-19 2017-06-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 48.750 72.043 209,29 52,03 2.536.462 3.748.397
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 34.000 34.000
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 40.000 40.000
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -800 23.293 -3,32 593,66 -474.928 13.828.122
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -23 24.093 -0,10 592,40 -13.625 14.272.693
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -957 24.116 -3,82 591,75 -566.305 14.270.643
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.486 25.073 -9,02 590,57 -1.468.157 14.807.362
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.542 27.559 -8,44 589,76 -1.499.170 16.253.196
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.126 30.101 -6,60 588,55 -1.251.257 17.715.944
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.482 32.227 -7,15 587,35 -1.457.803 18.928.528
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.007 34.709 -5,47 585,22 -1.174.537 20.312.401
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -29.236 0 -100,00
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -3.264 0 -100,00
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -14.292 36.716 -28,02 588,64 -8.412.843 21.612.506
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -1.521 51.008 -2,90 588,64 -895.321 30.025.349
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 29.236 52.529 125,51 30,63 895.499 1.608.963
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3.264 23.293 16,30 30,63 99.976 713.465
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -400 20.029 -1,96 454,00 -181.600 9.093.166
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.700 20.429 -7,68 453,28 -770.576 9.260.057
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.200 22.129 -12,63 452,61 -1.448.352 10.015.807
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -700 25.329 -2,69 450,95 -315.665 11.422.113
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.093 26.029 -7,44 450,18 -942.227 11.717.735
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -300 28.122 -1,06 448,87 -134.661 12.623.122
2015-03-18 2015-03-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.600 28.422 -8,38 448,01 -1.164.826 12.733.340
2015-03-18 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -24.375 29.236 -45,47
2015-03-18 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -11.703 31.022 -27,39 444,46 -5.201.515 13.788.038
2015-03-18 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.679 42.725 -3,78 444,46 -746.248 18.989.554
2015-03-18 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 24.375 44.404 121,70 30,63 746.606 1.360.095
2015-02-25 2015-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -11.173 20.029 -35,81 423,67 -4.733.665 8.485.686
2015-02-25 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -24.375 53.611 -31,26
2015-02-25 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -11.458 31.202 -26,86 427,94 -4.903.337 13.352.584
2015-02-25 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.744 42.660 -3,93 427,94 -746.327 18.255.920
2015-02-25 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 24.375 44.404 121,70 30,63 746.606 1.360.095
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 40.000 40.000
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 48.750 79.329 159,42
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.800 20.029 -8,25 408,62 -735.516 8.184.250
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.200 21.829 -9,16 407,85 -897.270 8.902.958
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.720 24.029 -13,41 406,89 -1.513.631 9.777.160
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -7.278 27.749 -20,78 405,85 -2.953.776 11.261.932
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -3.252 35.027 -8,50 404,75 -1.316.247 14.177.178
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.150 38.279 -5,32 403,86 -868.299 15.459.357
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -1.500 40.429 -3,58 402,71 -604.065 16.281.163
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -400 41.929 -0,94 401,42 -160.568 16.831.139
2014-11-19 2014-11-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -62 42.329 -0,15 400,45 -24.828 16.950.648
2014-11-19 2014-11-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -48.750 0 -100,00
2014-11-19 2014-11-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -23.810 42.391 -35,97 401,75 -9.565.668 17.030.584
2014-11-19 2014-11-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.578 66.201 -3,75 401,75 -1.035.712 26.596.252
2014-11-19 2014-11-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 48.750 68.779 243,40 21,25 1.035.938 1.461.554
2014-02-19 2014-02-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.765 20.029 -12,13 333,79 -922.929 6.685.480
2014-02-19 2014-02-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -6.603 22.794 -22,46 332,75 -2.197.148 7.584.704
2014-02-19 2014-02-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -3.497 29.397 -10,63 331,66 -1.159.815 9.749.809
2014-02-19 2014-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -27.795 48.750 -36,31
2014-02-19 2014-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -13.104 32.894 -28,49 323,30 -4.236.523 10.634.630
2014-02-19 2014-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -1.826 45.998 -3,82 323,30 -590.346 14.871.153
2014-02-19 2014-02-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 27.795 47.824 138,77 21,25 590.644 1.016.260
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4.705 0 -100,00
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 4.705 20.029 30,70 21,25 99.981 425.616
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 50.000 50.000
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 48.750 77.986 166,75
2013-05-09 2013-05-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -400 15.324 -2,54 262,06 -104.824 4.015.807
2013-05-09 2013-05-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -4.437 15.724 -22,01 261,44 -1.160.009 4.110.883
2013-05-09 2013-05-08 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -3.394 20.161 -14,41 260,86 -885.359 5.259.198
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2.173 0 -100,00
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14.750 2.173 -87,16
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -750 23.555 -3,09 261,67 -196.252 6.163.637
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -139 24.305 -0,57 261,67 -36.372 6.359.889
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 2.173 24.444 9,76 16,80 36.506 410.659
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -6.857 22.271 -23,54 261,67 -1.794.271 5.827.653
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -946 29.128 -3,15 261,67 -247.540 7.621.924
2013-05-09 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 14.750 30.074 96,25 16,80 247.800 505.243
2012-12-19 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5.952 0 -100,00
2012-12-19 2012-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 5.952 15.324 63,51 16,80 99.994 257.443
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 75.000 75.000
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 48.750 76.545 175,39
2012-11-26 2012-11-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.045 9.372 -17,91 175,09 -358.059 1.640.943
2012-11-26 2012-11-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -6.700 11.417 -36,98 174,33 -1.168.011 1.990.326
2012-11-26 2012-11-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.000 18.117 -5,23 173,90 -173.900 3.150.546
2012-11-26 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 16.923 -54,17
2012-11-26 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -8.323 19.117 -30,33 173,83 -1.446.787 3.323.108
2012-11-26 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -1.932 27.440 -6,58 173,83 -335.840 4.769.895
2012-11-26 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 29.372 213,40 16,80 336.000 493.450
2012-07-31 2012-07-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -2.334 9.372 -19,94 137,58 -321.112 1.289.400
2012-07-31 2012-07-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -6.600 11.706 -36,05 136,26 -899.316 1.595.060
2012-07-31 2012-07-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -14.833 18.306 -44,76 135,49 -2.009.723 2.480.280
2012-07-31 2012-07-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -67 33.139 -0,20 134,99 -9.044 4.473.434
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -12.500 0 -100,00
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -24.375 36.923 -39,76
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -14.000 61.298 -18,59
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -4.839 33.206 -12,72 137,39 -664.830 4.562.172
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.994 38.045 -4,98 137,39 -273.956 5.227.003
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.500 40.039 45,39 21,92 274.000 877.655
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -9.856 27.539 -26,36 137,39 -1.354.116 3.783.583
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.980 37.395 -7,38 137,39 -409.422 5.137.699
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 24.375 40.375 152,34 16,80 409.500 678.300
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.661 16.000 -26,13 137,39 -777.765 2.198.240
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.711 21.661 -7,32 137,39 -235.074 2.976.005
2012-07-31 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 14.000 23.372 149,38 16,80 235.200 392.650
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -900 9.372 -8,76 91,04 -81.936 853.227
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -8.539 10.272 -45,39 90,54 -773.121 930.027
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -23.128 12.500 -64,92
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -8.061 18.811 -30,00 90,07 -726.054 1.694.307
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -5.628 26.872 -17,32 90,07 -506.914 2.420.361
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 23.128 32.500 246,78 21,92 506.966 712.400
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)